Medicare Part D coverage · meropenem · RxCUI 1946651
meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]
Per the CMS 2026 Part D formulary file, meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] is covered by 37 Medicare Part D plans (0.7% of enrollable products), averaging Tier 4, with prior authorization required on 16.7% of covering formularies.
- 0.7%
- Plan coverage
- 37
- Plans covering
- T4
- Avg tier
- 16.7%
- Prior auth required
What the CMS Formulary Data Shows for meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]
Per the CMS 2026 Part D formulary file, meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] (RxNorm concept RXCUI 1946651, generic name meropenem) appears on 6 distinct formulary files spanning 37 Medicare Part D plan offerings - 0.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 5, with a cross-plan average of Tier 4.
Real-world access to meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] depends on utilization management as much as tier placement: 16.7% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 27,599 Part D beneficiaries filled meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] in 2023, with total plan-and-beneficiary spending of $19,803,852 and an average per-beneficiary annual cost of $717.56. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 37
- Coverage rate
- 0.7%
- Tier range
- Tier 2 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 16.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 27,599
- Total spending
- $19,803,852
- Avg per beneficiary
- $717.56
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]
37 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T4 | No | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T4 | No | $0 | NY |
| CDPHP $0 Medicare Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | No | $0 | NY |
| Univera SeniorChoice Core (PPO) | Excellus Health Plan, Inc. | T4 | No | $33.00 | NY |
| Univera SeniorChoice Advanced (HMO-POS) | Excellus Health Plan, Inc. | T4 | No | $36.90 | NY |
| Medicare BlueClassic (PPO) | Excellus Health Plan, Inc. | T4 | No | $51.00 | NY |
| Univera SeniorChoice Secure (HMO-POS) | Excellus Health Plan, Inc. | T4 | No | $54.90 | NY |
| Medicare BlueBalanced (PPO) | Excellus Health Plan, Inc. | T4 | No | $55.00 | NY |
| Medicare Blue Choice Prime (HMO) | Excellus Health Plan, Inc. | T4 | No | $55.00 | NY |
| Univera SeniorChoice Value Plus (HMO-POS) | Excellus Health Plan, Inc. | T4 | No | $58.60 | NY |
| Medicare BlueEnhanced (PPO) | Excellus Health Plan, Inc. | T4 | No | $70.30 | NY |
| Medicare BluePlus (PPO) | Excellus Health Plan, Inc. | T4 | No | $86.40 | NY |
| CDPHP Clear Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | No | $100.00 | NY |
Show the next 17 plans
| CDPHP Choice Rx (HMO) | Capital District Physicians' Health Plan, Inc. | T4 | No | $135.00 | NY |
| Medicare Blue Choice Optimum (HMO-POS) | Excellus Health Plan, Inc. | T4 | No | $146.00 | NY |
| UPMC for Life HMO Premier Rx (HMO) | Upmc Health Plan, Inc. | T5 | No | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | No | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc FOR YOU, Inc | T5 | No | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | No | $0 | PA |
| UPMC for Life PPO Premier Rx (PPO) | Upmc Health Network, Inc. | T5 | No | $0 | PA |
| UPMC for Life PPO Essential Care Rx (PPO) | Upmc Health Network, Inc. | T5 | No | $0 | PA |
| UPMC for Life Complete Care (HMO D-SNP) | Upmc Health Coverage, Inc. | T5 | No | $0 | PA |
| UPMC for Life HMO Rx Choice (HMO) | Upmc Health Plan, Inc. | T5 | No | $3.90 | OH, PA |
| UPMC for Life HMO Deductible Rx (HMO) | Upmc Health Plan, Inc. | T5 | No | $18.10 | OH, PA |
| UPMC for Life PPO Rx Choice (PPO) | Upmc Health Network, Inc. | T5 | No | $25.00 | PA |
| UPMC for Life PPO High Deductible Rx (PPO) | Upmc Health Network, Inc. | T5 | No | $33.00 | PA |
| UPMC for Life HMO Rx (HMO) | Upmc Health Plan, Inc. | T5 | No | $33.70 | OH, PA |
| UPMC for Life PPO Rx Enhanced (PPO) | Upmc Health Network, Inc. | T5 | No | $42.70 | PA |
| UPMC for Life HMO Rx Enhanced (HMO) | Upmc Health Plan, Inc. | T5 | No | $93.40 | OH, PA |
| UPMC for Life PPO Rx Enhanced (PPO) | Upmc Health Network, Inc. | T5 | No | $140.00 | PA |
Frequently Asked Questions
Is meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] covered by Medicare Part D?
Yes, meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] is covered by 37 Medicare Part D plans (0.7% of all Part D formularies).
What tier is meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] on Medicare Part D plans?
meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] averages Tier 4 across Part D plans, ranging from Tier 2 to Tier 5.
Does meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] require prior authorization?
16.7% of Part D formularies require prior authorization for meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]?
In 2023, total Medicare Part D spending on meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere] was $19,803,852, covering 27,599 beneficiaries. The average spend per beneficiary was $717.56.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray T4
- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] T4
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia] T4
- timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] T4
- deflazacort 18 MG Oral Tablet [Jaythari] T4
- bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] T4
Similar prior-authorization rate
- quetiapine 150 MG Oral Tablet 16.7% PA
- naldemedine 0.2 MG Oral Tablet [Symproic] 16.7% PA
- ziprasidone 20 MG Injection 16.8% PA
- morphine sulfate 20 MG/ML Oral Solution 16.9% PA
- 1000 ML glucose 100 MG/ML / sodium chloride 4.5 MG/ML Injection 16.5% PA
- chlorpromazine hydrochloride 50 MG Oral Tablet 16.5% PA